Oncolytics Biotech
ONCY
#9837
Rank
A$0.13 B
Marketcap
A$1.08
Share price
-1.44%
Change (1 day)
-43.19%
Change (1 year)

Earnings for Oncolytics Biotech (ONCY)

Earnings in 2026 (TTM): -A$49.21 Million

According to Oncolytics Biotech 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$40.62 Million a decrease over its 2024 earnings that were of -A$34.28 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oncolytics Biotech from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$49.21 Million21.16%
2025 -A$40.62 Million18.49%
2024 -A$34.28 Million-5.22%
2023 -A$36.16 Million24.73%
2022 -A$28.99 Million-1.09%
2021 -A$29.31 Million5.72%
2020 -A$27.73 Million25.24%
2019 -A$22.14 Million28.77%
2018 -A$17.19 Million1.15%
2017 -A$17 Million5.2%
2016 -A$16.16 Million9.85%
2015 -A$14.71 Million-36.67%
2014 -A$23.23 Million-26.64%
2013 -A$31.66 Million-38.4%
2012 -A$51.39 Million27%
2011 -A$40.46 Million44.32%
2010 -A$28.04 Million35.97%
2009 -A$20.62 Million-3.27%
2008 -A$21.32 Million-10.71%
2007 -A$23.88 Million28.33%
2006 -A$18.61 Million40.52%
2005 -A$13.24 Million-13.75%
2004 -A$15.35 Million115.72%
2003 -A$7.12 Million16.58%
2002 -A$6.11 Million-4.4%
2001 -A$6.39 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
A$43.90 B-94,283.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.53 B-29,140.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
-A$1.08 Billion 2,214.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-A$7.74 Million-83.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.20 B-6,971.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
-A$40.97 Million-12.13%๐Ÿ‡บ๐Ÿ‡ธ USA